Human immunodeficiency virus type 1 vpr protein transactivation function: mechanism and identification of domains involved
- PMID: 9837715
- DOI: 10.1006/jmbi.1998.2206
Human immunodeficiency virus type 1 vpr protein transactivation function: mechanism and identification of domains involved
Abstract
The human immunodeficiency virus type 1 (HIV-1) Vpr protein is a virion-associated protein that localizes in the nucleus of infected cells. Vpr has been shown to facilitate HIV infection of non-dividing cells such as macrophages by contributing to the nuclear translocation of the pre-integration complex. More recently, Vpr expression has been shown to induce an accumulation of cells at the G2 phase of the cell-cycle. We have previously reported that Vpr stimulates reporter gene expression directed from the HIV-1 long terminal repeat (LTR) as well as from heterologous viral promoters. However, the mode of action of Vpr-mediated transactivation remains to be precisely defined. We report here that, for a constant amount of transfected DNA, the level of chloramphenicol acetyltransferase (CAT) mRNA is increased in Vpr-expressing cells using either HIV-1 or a murine leukemia virus (MLV) SL3-3 LTR-CAT reporter construct. Moreover, this Vpr-mediated transactivation requires that promoters direct a minimal level of basal expression. Our mutagenic analysis indicates that the transactivation mediated by Vpr is not dependent on the ability of the protein to localize in the nucleus or to be packaged in the virions. Interestingly, all transactivation-competent Vpr mutants were still able to induce a cell-cycle arrest. Conversely, transactivation-defective mutants lost the ability to mediate cell-cycle arrest, implying a functional relationship between these two functions. Overall, our results indicate that the G2 cell-cycle arrest mediated by Vpr creates a cellular environment where the HIV-1 LTR is transcriptionally more active.
Copyright 1998 Academic Press.
Similar articles
-
Structure-functional analysis of human immunodeficiency virus type 1 (HIV-1) Vpr: role of leucine residues on Vpr-mediated transactivation and virus replication.Virology. 2004 Oct 10;328(1):89-100. doi: 10.1016/j.virol.2004.07.013. Virology. 2004. PMID: 15380361
-
Transactivation is a conserved function among primate lentivirus Vpr proteins but is not shared by Vpx.J Hum Virol. 1999 May-Jun;2(3):167-74. J Hum Virol. 1999. PMID: 10413368
-
A carboxy-terminally truncated form of the Vpr protein of human immunodeficiency virus type 1 retards cell proliferation independently of G(2) arrest of the cell cycle.Virology. 1999 Oct 25;263(2):313-22. doi: 10.1006/viro.1999.9905. Virology. 1999. PMID: 10544105
-
Human immunodeficiency virus type-1 accessory protein Vpr: a causative agent of the AIDS-related insulin resistance/lipodystrophy syndrome?Ann N Y Acad Sci. 2004 Jun;1024:153-67. doi: 10.1196/annals.1321.013. Ann N Y Acad Sci. 2004. PMID: 15265780 Review.
-
Partner molecules of accessory protein Vpr of the human immunodeficiency virus type 1.DNA Cell Biol. 2004 Apr;23(4):193-205. doi: 10.1089/104454904773819789. DNA Cell Biol. 2004. PMID: 15142377 Review.
Cited by
-
Impacts of humanized mouse models on the investigation of HIV-1 infection: illuminating the roles of viral accessory proteins in vivo.Viruses. 2015 Mar 23;7(3):1373-90. doi: 10.3390/v7031373. Viruses. 2015. PMID: 25807049 Free PMC article. Review.
-
Impairment of human immunodeficiency virus type 1 (HIV-1) entry into Jurkat T cells by constitutive expression of the HIV-1 vpr protein: role of CD4 down-modulation.J Virol. 2000 Nov;74(21):10207-11. doi: 10.1128/jvi.74.21.10207-10211.2000. J Virol. 2000. PMID: 11024150 Free PMC article.
-
Activation of transcription factors NF-kappaB and NF-IL-6 by human immunodeficiency virus type 1 protein R (Vpr) induces interleukin-8 expression.J Virol. 2000 May;74(10):4658-65. doi: 10.1128/jvi.74.10.4658-4665.2000. J Virol. 2000. PMID: 10775602 Free PMC article.
-
The first HxRxG motif in simian immunodeficiency virus mac239 Vpr is crucial for G(2)/M cell cycle arrest.J Virol. 2002 Nov;76(22):11704-9. doi: 10.1128/jvi.76.22.11704-11709.2002. J Virol. 2002. PMID: 12388729 Free PMC article.
-
Resistance to the Tat Inhibitor Didehydro-Cortistatin A Is Mediated by Heightened Basal HIV-1 Transcription.mBio. 2019 Jul 2;10(4):e01750-18. doi: 10.1128/mBio.01750-18. mBio. 2019. PMID: 31266880 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous